Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer
Christoforos Thomas et al.
CANCER RESEARCH (2021)
Preexisting Somatic Mutations of Estrogen Receptor Alpha (ESR1) in Early-Stage Primary Breast Cancer
Malin Dahlgren et al.
JNCI CANCER SPECTRUM (2021)
Absence of estrogen receptor is associated with worse oncologic outcome in patients who were received neoadjuvant chemotherapy for breast cancer
Young Ryul Park et al.
ASIAN JOURNAL OF SURGERY (2020)
Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues
John R. Hawse et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer
Manoj Kumar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
The mutational landscape of theSCAN-B real-world primary breast cancer transcriptome
Christian Brueffer et al.
EMBO MOLECULAR MEDICINE (2020)
Breast cancer gene expression datasets do not reflect the disease at the population level
Yanping Xie et al.
NPJ BREAST CANCER (2020)
The role of estrogen receptor beta in breast cancer
Yujing Zhou et al.
BIOMARKER RESEARCH (2020)
Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer
Aristomenis Anestis et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy
Peiye Song et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Daehwan Kim et al.
NATURE BIOTECHNOLOGY (2019)
Raloxifene nano-micelles effect on triple-negative breast cancer is mediated through estrogen receptor-β and epidermal growth factor receptor
Khaled Greish et al.
JOURNAL OF DRUG TARGETING (2019)
Tumor-infiltrating B cells signal functional humoral immune responses in breast cancer
Soizic Garaud et al.
JCI INSIGHT (2019)
Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative
L. Ryden et al.
BRITISH JOURNAL OF SURGERY (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms
Meng Shen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation
Nicolas Leblanc et al.
ANTICANCER RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
David Austin et al.
Oncotarget (2018)
High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort
Karin Elebro et al.
CLINICAL CANCER RESEARCH (2017)
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
Adam W. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
Jing Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Expression of ERβ gene in breast carcinoma and the relevance in neoadjuvant therapy
Jing Chang et al.
ONCOLOGY LETTERS (2017)
ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity
Mohamed Oueslati et al.
ONCOLOGY LETTERS (2017)
Insufficient antibody validation challenges oestrogen receptor beta research
Sandra Andersson et al.
NATURE COMMUNICATIONS (2017)
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes
Sami Benzina et al.
ONCOTARGET (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
ERβ overexpression results in endocrine therapy resistance and poor prognosis in postmenopausal ERα-positive breast cancer patients
Liying Guo et al.
ONCOLOGY LETTERS (2016)
The immune System Is a natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases
Deena Khan et al.
FRONTIERS IN IMMUNOLOGY (2016)
ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer
Jin Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspects
Yoko Omoto et al.
CANCER SCIENCE (2015)
Estrogen receptors regulate innate immune cells and signaling pathways
Susan Kovats
CELLULAR IMMUNOLOGY (2015)
The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents
Daniel Gabriel Pons et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
Mihaela Pertea et al.
NATURE BIOTECHNOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
Liying Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine
Lao H. Saal et al.
GENOME MEDICINE (2015)
Biologic Roles of Estrogen Receptor-β and Insulin-Like Growth Factor-2 in Triple-Negative Breast Cancer
Nalo Hamilton et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Preferential Estrogen Receptor β Ligands Reduce Bcl-2 Expression in Hormone-Resistant Breast Cancer Cells to Increase Autophagy
Samantha Ruddy et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Correlation between estrogen receptor β expression and the curative effect of endocrine therapy in breast cancer patients
Liying Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Estrogen receptor α and β in the normal immune system and in lymphoid malignancies
Konstantin Yakimchuk et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
Jing Wang et al.
NUCLEIC ACIDS RESEARCH (2013)
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer
M. Razandi et al.
ONCOGENE (2013)
Toward a Genome-Wide Landscape of Translational Control
Ola Larsson et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients
Sameer Mirza et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
Michel van Kruchten et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression
Zhenzhen Tu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
Max Yan et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Phosphorylation of Estrogen Receptor β at Serine 105 Is Associated with Good Prognosis in Breast Cancer
Werbena Hamilton-Burke et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
BASE-2nd generation software for microarray data management and analysis
Johan Vallon-Christersson et al.
BMC BIOINFORMATICS (2009)
Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
Naoko Honma et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
Sofia K. Gruvberger-Saal et al.
CLINICAL CANCER RESEARCH (2007)
WebGestalt: an integrated system for exploring gene sets in various biological contexts
B Zhang et al.
NUCLEIC ACIDS RESEARCH (2005)
Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer
LC Collins et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Molecular profiling of breast cancer: clinical implications
S Cleator et al.
BRITISH JOURNAL OF CANCER (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer
TA Hopp et al.
CLINICAL CANCER RESEARCH (2004)
Altered expression pattern of alternatively spliced estrogen receptor β transcripts in breast carcinoma
I Girault et al.
CANCER LETTERS (2004)
Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction -: Correlation with protein assays
P de Cremoux et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Quantification of estrogen receptor α and β expression in sporadic breast cancer
I Bièche et al.
ONCOGENE (2001)
Prognostic and predictive factors in breast cancer
NJ Bundred
CANCER TREATMENT REVIEWS (2001)
Share Paper
